14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Hypertriglyceridemia in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chadderdon, SM | 1 |
Belcik, JT | 1 |
Smith, E | 1 |
Pranger, L | 1 |
Kievit, P | 1 |
Grove, KL | 1 |
Lindner, JR | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance[NCT02060240] | 30 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Hypertriglyceridemia
Article | Year |
---|---|
Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Brachial Artery; Capillaries; Contrast Media; Glucose Toleranc | 2012 |